We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, devel... read more Featured Products: More products

Download Mobile App




Rare Parasite Causes Relapsing Febrile Myositis

By LabMedica International staff writers
Posted on 19 Jun 2014
Sarcocystis species are protozoan organisms that have been associated with disease in animals but less frequently so in humans, where symptoms such as myalgia, muscle weakness and transitory edema may occur. More...


Humans can become hosts for Sarcocystis species by consuming food or water contaminated with fecal sporocysts from an infected definitive host and in such cases, hematogenous dissemination can occur with invasion of muscle leading to sarcocysts.

Scientists at the University of Malaya (Kuala Lumpur, Malaysia) investigated an outbreak of acute, relapsing febrile myositis that occurred in a group of 92 college students and teachers that had attended a retreat in a hotel located on Pangkor Island, off the west coast of Peninsular Malaysia. Investigations included full blood counts (FBC), renal function tests (RFT), liver function tests (LFT), serum creatine kinase (CK) levels, chest X-rays, blood cultures, and blood films for malarial parasites.

Serological testing was done for Chikungunya virus, Dengue virus, Legionella, Mycoplasma, and Leptospira. Testing was performed using an in-house immunofluorescence assay for detection of chikungunya immunoglobulin M (IgM) and IgG; anti-dengue IgM and IgG capture ELISA (Standard Diagnostics; Yongin, Korea) for detection of dengue IgM and IgG; immunofluorescence assays for detection of Legionella IgG (MarDx Diagnostics, Inc.; Bray, Ireland) and Legionella IgM (Vircell; Granada, Spain); SERODIA-MYCO II (Fujirebio Inc.; Tokyo,Japan) for detection of Mycoplasma total antibodies.

Sarcocystis serology was done by an immunoblot assay using S. neurona merozoite-derived antigens (Centers of Disease Control; Atlanta, GA, USA) in 10 patients. Muscle biopsies from affected sites in four patients with myalgia and Magnetic resonance imaging (MRI) abnormalities were fixed in buffered 10% formalin and routinely processed. Hematoxylin and eosin stained tissue sections were examined by light microscopy. Polymerase chain reaction (PCR) for Sarcocystis spp. was performed on all four biopsies.

Out of four muscle biopsies, sarcocysts were identified in three. S. nesbitti was identified by PCR in three of the four biopsies including one biopsy without an observed sarcocyst. Non-Malaysians had a median duration of symptoms of 27.5 days which was longer than that of 14 days for Malaysians, and the Non-Malaysians were more likely to experience moderate or severe myalgia compared to mild myalgia. None of the other serology tests for dengue, Legionella, Mycoplasma, or Leptospira were consistent with recent infection. Sarcocystis spp. were not detected by PCR in any water samples.

The authors conclude that the similarity of the symptoms and clustered time of onset suggests that all affected persons had muscular sarcocystosis. This was the largest human outbreak of sarcocystosis ever reported, with the specific Sarcocystis species identified. The largely nonspecific clinical features of this illness suggest that S. nesbitti may be an under diagnosed infection in the tropics. The study was published on May 22, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of Malaya
Vircell
Fujirebio Inc.




Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.